COMPARISON OF CLINICAL ACTIVITY OF PIMECROLIMUS IN PEDIATRIC PATIENTS WITH MILD AND MODERATE ATOPIC DERMATITIS
Atopic dermatitis (ad) is prevalent disease in younger children. Calcium inhibitor pimecrolimus (elidel, cream 1%) is the latest anti-inflammatory drug offered for management of ad. The activity of pimecrolimus was evaluated in open, prospective, randomized, comparison trial, on 60 children (age fro...
Saved in:
Main Authors: | E.V. Deeva (Author), L.M. Ogorodova (Author), I.A. Deev (Author), I.V. Sheveleva (Author) |
---|---|
Format: | Book |
Published: |
"Paediatrician" Publishers LLC,
2008-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
COMPARISON OF CLINICAL ACTIVITY OF PIMECROLIMUS IN PEDIATRIC PATIENTS WITH MILD AND MODERATE ATOPIC DERMATITIS
by: E.V. Deeva, et al.
Published: (2008) -
PIMECROLIMUS (1% CREAM) IN TREATMENT OF ATOPIC DERMATITIS AMONG CHILDREN: EFFICIENCY AND SAFETY
by: L.M. Ogorodova, et al.
Published: (2007) -
PIMECROLIMUS (1% CREAM) IN TREATMENT OF ATOPIC DERMATITIS AMONG CHILDREN: EFFICIENCY AND SAFETY
by: L.M. Ogorodova, et al.
Published: (2007) -
ATOPIC DERMATITIS AMONG CHILDREN: ZONE OF CLINICAL SUPERVISION
by: L.M. Ogorodova, et al.
Published: (2007) -
ATOPIC DERMATITIS AMONG CHILDREN: ZONE OF CLINICAL SUPERVISION
by: L.M. Ogorodova, et al.
Published: (2007)